Literature DB >> 29806717

Towards the complex dependence of MTRasym on T1w in amide proton transfer (APT) imaging.

Zhongliang Zu1,2.   

Abstract

Amide proton transfer (APT) imaging is a variation of chemical exchange saturation transfer MRI that has shown promise in diagnosing tumors, ischemic stroke, multiple sclerosis, traumatic brain injury, etc. Specific quantification of the APT effect is crucial for the interpretation of APT contrast in pathologies. Conventionally, magnetization transfer ratio with asymmetric analysis (MTRasym ) has been used to quantify the APT effect. However, some studies indicate that MTRasym is contaminated by water longitudinal relaxation time (T1w ), and thus it is necessary to normalize T1w in MTRasym to obtain specific quantification of the APT effect. So far, whether to use MTRasym or the T1w -normalized MTRasym is still under debate in the field. In this paper, the influence of T1w on the quantification of APT was evaluated through theoretical analysis, numerical simulations, and phantom studies for different experimental conditions. Results indicate that there are two types of T1w effect (T1w recovery and T1w -related saturation), which have inverse influences on the steady-state MTRasym . In situations with no or weak direct water saturation (DS) effect, there is only the T1w recovery effect, and MTRasym linearly depends on T1w . In contrast, in situations with significant DS effects, the dependence of MTRasym on T1w is complex, and is dictated by the competition of these two T1w effects. Therefore, by choosing appropriate irradiation powers, MTRasym could be roughly insensitive to T1w . Moreover, in non-steady-state acquisitions with very short irradiation time, MTRasym is also roughly insensitive to T1w . Therefore, for steady-state APT imaging at high fields or with very low irradiation powers, where there are no significant DS effects, it is necessary to normalize T1w to improve the specificity of MTRasym . However, in clinical MRI systems (usually low fields or non-steady-state acquisitions), T1w normalization may not be necessary when appropriate sequence parameters are chosen.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  MRI; T1w normalization; amide proton transfer (APT); chemical exchange saturation transfer (CEST)

Mesh:

Substances:

Year:  2018        PMID: 29806717      PMCID: PMC6089235          DOI: 10.1002/nbm.3934

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  45 in total

1.  Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semisolid magnetization transfer reference (EMR) signals: II. Comparison of three EMR models and application to human brain glioma at 3 Tesla.

Authors:  Hye-Young Heo; Yi Zhang; Shanshan Jiang; Dong-Hoon Lee; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2015-05-28       Impact factor: 4.668

2.  Amide proton transfer imaging of human brain tumors at 3T.

Authors:  Craig K Jones; Michael J Schlosser; Peter C M van Zijl; Martin G Pomper; Xavier Golay; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2006-09       Impact factor: 4.668

3.  Chemical exchange saturation transfer (CEST): what is in a name and what isn't?

Authors:  Peter C M van Zijl; Nirbhay N Yadav
Journal:  Magn Reson Med       Date:  2011-02-17       Impact factor: 4.668

4.  Mechanism of magnetization transfer during on-resonance water saturation. A new approach to detect mobile proteins, peptides, and lipids.

Authors:  Peter C M van Zijl; Jinyuan Zhou; Noriko Mori; Jean-Francois Payen; David Wilson; Susumu Mori
Journal:  Magn Reson Med       Date:  2003-03       Impact factor: 4.668

5.  Saturation power dependence of amide proton transfer image contrasts in human brain tumors and strokes at 3 T.

Authors:  Xuna Zhao; Zhibo Wen; Fanheng Huang; Shilong Lu; Xianlong Wang; Shuguang Hu; Donglin Zu; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2011-03-10       Impact factor: 4.668

6.  Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI.

Authors:  Liu Qi Chen; Christine M Howison; Justin J Jeffery; Ian F Robey; Phillip H Kuo; Mark D Pagel
Journal:  Magn Reson Med       Date:  2013-11-26       Impact factor: 4.668

7.  Investigating GluCEST and its specificity for pH mapping at low temperatures.

Authors:  Felizitas C Wermter; Christian Bock; Wolfgang Dreher
Journal:  NMR Biomed       Date:  2015-09-28       Impact factor: 4.044

8.  PARACEST MRI with improved temporal resolution.

Authors:  Guanshu Liu; M Meser Ali; Byunghee Yoo; Mark A Griswold; Jean A Tkach; Mark D Pagel
Journal:  Magn Reson Med       Date:  2009-02       Impact factor: 4.668

9.  Amide proton transfer (APT) contrast for imaging of brain tumors.

Authors:  Jinyuan Zhou; Bachchu Lal; David A Wilson; John Laterra; Peter C M van Zijl
Journal:  Magn Reson Med       Date:  2003-12       Impact factor: 4.668

10.  Magnetic resonance imaging of glutamate.

Authors:  Kejia Cai; Mohammad Haris; Anup Singh; Feliks Kogan; Joel H Greenberg; Hari Hariharan; John A Detre; Ravinder Reddy
Journal:  Nat Med       Date:  2012-01-22       Impact factor: 53.440

View more
  22 in total

1.  Approximated analytical characterization of the steady-state chemical exchange saturation transfer (CEST) signals.

Authors:  Tao Jin; Seong-Gi Kim
Journal:  Magn Reson Med       Date:  2019-06-24       Impact factor: 4.668

2.  CEST MR-Fingerprinting: Practical considerations and insights for acquisition schedule design and improved reconstruction.

Authors:  Or Perlman; Kai Herz; Moritz Zaiss; Ouri Cohen; Matthew S Rosen; Christian T Farrar
Journal:  Magn Reson Med       Date:  2019-08-09       Impact factor: 4.668

3.  Prospective acceleration of parallel RF transmission-based 3D chemical exchange saturation transfer imaging with compressed sensing.

Authors:  Hye-Young Heo; Xiang Xu; Shanshan Jiang; Yansong Zhao; Jochen Keupp; Kristin J Redmond; John Laterra; Peter C M van Zijl; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2019-06-17       Impact factor: 4.668

4.  Consistent depiction of the acidic ischemic lesion with APT MRI-Dual RF power evaluation of pH-sensitive image in acute stroke.

Authors:  Phillip Zhe Sun
Journal:  Magn Reson Med       Date:  2021-09-30       Impact factor: 4.668

5.  3D Amide Proton Transfer-Weighted Imaging for Grading Glioma and Correlating IDH Mutation Status: Added Value to 3D Pseudocontinuous Arterial Spin Labelling Perfusion.

Authors:  Huimin Hou; Weibo Chen; Yanzhao Diao; Yuhan Wang; Li Zhang; Liming Wang; Min Xu; Jinchao Yu; Tao Song; Yu Liu; Zhenguo Yuan
Journal:  Mol Imaging Biol       Date:  2022-08-12       Impact factor: 3.484

6.  Quasi-steady-state amide proton transfer (QUASS APT) MRI enhances pH-weighted imaging of acute stroke.

Authors:  Phillip Zhe Sun
Journal:  Magn Reson Med       Date:  2022-08-19       Impact factor: 3.737

7.  Investigating the origin of pH-sensitive magnetization transfer ratio asymmetry MRI contrast during the acute stroke: Correction of T1 change reveals the dominant amide proton transfer MRI signal.

Authors:  Limin Wu; Liang Jiang; Phillip Zhe Sun
Journal:  Magn Reson Med       Date:  2020-05-16       Impact factor: 4.668

8.  Amide proton transfer-weighted MRI for predicting histological grade of hepatocellular carcinoma: comparison with diffusion-weighted imaging.

Authors:  Yue Lin; Xiaojie Luo; Lu Yu; Yi Zhang; Jinyuan Zhou; Yuwei Jiang; Chen Zhang; Jintao Zhang; Chunmei Li; Min Chen
Journal:  Quant Imaging Med Surg       Date:  2019-10

9.  Chemical exchange rotation transfer imaging of phosphocreatine in muscle.

Authors:  Zhongliang Zu; Eugene C Lin; Elizabeth A Louie; Xiaoyu Jiang; Christopher L Lankford; Bruce Damon; Mark D Does; John C Gore; Daniel F Gochberg
Journal:  NMR Biomed       Date:  2020-12-07       Impact factor: 4.044

10.  Quasi-steady-state chemical exchange saturation transfer (QUASS CEST) MRI analysis enables T1 normalized CEST quantification - Insight into T1 contribution to CEST measurement.

Authors:  Phillip Zhe Sun
Journal:  J Magn Reson       Date:  2021-06-08       Impact factor: 2.734

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.